Old Drug, New Tricks? How the BPCIA Could Increase Generic Competition for Insulins
June 23, 2020
By: Ted Mathias and Rebecca Clegg
BioProcess Online / Biosimilar Development
BioProcess Online and Biosimilar Development published "Old Drug, New Tricks? How the BPCIA Could Increase Generic Competition for Insulins," an article written by Axinn partnerTed Mathias and associate Rebecca Clegg.
Click to access the article on BioProcess Online and Biosimilar Development.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 34th Annual Advanced EU Brussels Conference
Speaking Engagement
Antitrust
Kisaco Research Pharma and Biotech Patent Litigation Summit 2025
Speaking Engagement
Intellectual Property
GCR Live: Women in Antitrust 2025
Speaking Engagement
Antitrust
Global Legal Group Global Class Actions Symposium 2025
Speaking Engagement
Litigation & Trials
ITCTLA Mock Hearing Program 2025
Speaking Engagement
Intellectual Property
IBA Annual Conference 2025
Speaking Engagement
Antitrust
GCR Live: Global Merger Control 2025
Speaking Engagement
Antitrust
Patent Eligibility in the AI Era: Aligning Judicial Precedent With USPTO Guidance
Byline Articles
Intellectual Property
Thomson Reuters 24th Annual Law Firm COO & CFO Forum
Speaking Engagement
LegalNEXT 2025
Speaking Engagement
Antitrust

